We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
MOUNJARO Eli Lilly Australia Pty Ltd
Product name
MOUNJARO
Sponsor
Accepted date
Sep-2024
Active ingredients
tirzepatide
Proposed indication
Treatment of moderate to severe obstructive sleep
apnoea (repeated stopping and starting of breathing during sleep) in adults with obesity.
apnoea (repeated stopping and starting of breathing during sleep) in adults with obesity.
Application type
C (new indication)
Publication date
Sep-2024